pioglitazone hydrochloride and metformin hydrochloride
Generic: pioglitazone hydrochloride and metformin hydrochloride
Labeler: rising pharma holdings, inc.Drug Facts
Product Profile
Brand Name
pioglitazone hydrochloride and metformin hydrochloride
Generic Name
pioglitazone hydrochloride and metformin hydrochloride
Labeler
rising pharma holdings, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
metformin hydrochloride 500 mg/1, pioglitazone hydrochloride 15 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
57237-217
Product ID
57237-217_e1c4f0ca-4474-4bac-8884-8180e7aec050
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA200823
Listing Expiration
2026-12-31
Marketing Start
2013-02-13
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
57237217
Hyphenated Format
57237-217
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
pioglitazone hydrochloride and metformin hydrochloride (source: ndc)
Generic Name
pioglitazone hydrochloride and metformin hydrochloride (source: ndc)
Application Number
ANDA200823 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/1
- 15 mg/1
Packaging
- 60 TABLET, FILM COATED in 1 BOTTLE (57237-217-60)
- 180 TABLET, FILM COATED in 1 BOTTLE (57237-217-81)
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e1c4f0ca-4474-4bac-8884-8180e7aec050", "openfda": {"upc": ["0357237218600", "0357237217603"], "unii": ["JQT35NPK6C", "786Z46389E"], "rxcui": ["861783", "861822"], "spl_set_id": ["8d252dab-e868-42d3-95ea-69423d909e84"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (57237-217-60)", "package_ndc": "57237-217-60", "marketing_start_date": "20130213"}, {"sample": false, "description": "180 TABLET, FILM COATED in 1 BOTTLE (57237-217-81)", "package_ndc": "57237-217-81", "marketing_start_date": "20130213"}], "brand_name": "Pioglitazone Hydrochloride and Metformin Hydrochloride", "product_id": "57237-217_e1c4f0ca-4474-4bac-8884-8180e7aec050", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Biguanide [EPC]", "Biguanides [CS]", "Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator Receptor gamma Agonist [EPC]", "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]", "Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]", "Thiazolidinedione [EPC]", "Thiazolidinediones [CS]"], "product_ndc": "57237-217", "generic_name": "Pioglitazone Hydrochloride and Metformin Hydrochloride", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pioglitazone Hydrochloride and Metformin Hydrochloride", "active_ingredients": [{"name": "METFORMIN HYDROCHLORIDE", "strength": "500 mg/1"}, {"name": "PIOGLITAZONE HYDROCHLORIDE", "strength": "15 mg/1"}], "application_number": "ANDA200823", "marketing_category": "ANDA", "marketing_start_date": "20130213", "listing_expiration_date": "20261231"}